相关实验视频

Updated: Sep 18, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

巴林丁:一种临床口服小分子TNFα抑制剂

Alexander Dömling¹, Tad A Holak²

¹Innovative Chemistry Group Institute for Molecular and Translational Medicine (IMTM) and Czech Advanced Technology and Research Institute (CATRIN), Univerzita Palackého v Olomouci, Olomouc, 779 00, Czechia.

|June 20, 2025

概括

一种口服小分子Balinatunfib通过稳定一个非功能性三分体,有效地抑制瘤亡因子α (TNFα). 这种方法为治疗炎症性疾病的生物药物提供了有希望的替代品.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
药物发现药物发现药物发现

背景情况:

炎症反应在疾病中很常见,需要有效的药理疗法.
瘤亡因子α (TNFα) 是炎症和自身免疫性疾病中的关键细胞因子.
目前的生物TNFα抑制剂具有局限性,包括血脑屏障的穿透性较差和亲肠道给药.

研究的目的:

评估小分子巴利纳尼布 (SAR441566) 作为向TNFα的口服治疗药物的疗效.
调查balinatunfib在稳定TNFα到受体不合适的构造中的作用机制.
在临床前模型中,比较balinatunfib的抗炎作用与现有的生物疗法.

主要方法:

开发一种口服可用的小分子,balinatunfib,旨在全质抑制TNFα.
使用临床前模型来评估balinatunfib的抗炎疗效和作用机制.
评估balinatunfib防止TNFα受体结合和下游信号传递的能力.

主要成果:

在临床前模型中,Balinatunfib表现出与生物疗法相比较的抗炎作用.
小分子成功地使TNFα稳定在扭曲的,受体无能的三元体构造中.
口服巴利纳尼布 (balinatunfib) 对患者的遵守和中枢神经系统的可访问性有潜在的优势.

结论:

小分子可以实现TNFα的高亲和度,基于构造的抑制.
巴林丁代表了一种用于管理TNFα介导炎症性疾病的新疗法策略.
口服的小分子向TNFα可能提供一种新的治疗类别,可改善可访问性和遵守性.

关键词:

这就是TNFα.自身免疫性疾病自身免疫性疾病这是一种炎症炎症炎症炎症.蛋白质蛋白质相互作用小分子的小分子.

更多相关视频

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method

Published on: September 16, 2017

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.